Future Doc, Onko Sure detects lung cancer better than colon cancer. The problem is FDA approval. There is no current blood test for monitoring lung cancer so no predicate.
First of all, before anyone thinks Onko Sure is going to develop billions in sales, they need to see what doctors think of any new data they come up with for CRC. If you do not see any gain in market share by the end of the year, additional funding is going to be tough for a company on the pink sheets.
Even if doctors began using Onko Sure, the gain in sales would be too slow to help them financially. I don't think India will pan out but IMO, that is the only hope for current shareholders.
News 
Market Data 
Discover 
